Trexquant Investment LP lowered its position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 84.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 40,368 shares of the company’s stock after selling 222,046 shares during the period. Trexquant Investment LP’s holdings in Cardinal Health were worth $4,774,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of CAH. Norges Bank acquired a new position in shares of Cardinal Health in the fourth quarter valued at approximately $246,748,000. State Street Corp increased its position in Cardinal Health by 4.6% in the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company’s stock valued at $1,566,913,000 after acquiring an additional 627,253 shares during the period. Raymond James Financial Inc. bought a new position in shares of Cardinal Health during the fourth quarter valued at $45,115,000. KLP Kapitalforvaltning AS acquired a new position in shares of Cardinal Health during the fourth quarter worth $21,336,000. Finally, Proficio Capital Partners LLC bought a new stake in shares of Cardinal Health in the fourth quarter worth $14,995,000. Institutional investors and hedge funds own 87.17% of the company’s stock.
Cardinal Health Price Performance
CAH stock opened at $129.37 on Friday. The company’s 50-day moving average is $129.15 and its 200-day moving average is $121.62. The stock has a market capitalization of $31.25 billion, a PE ratio of 24.14, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $139.50.
Cardinal Health Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.56%. Cardinal Health’s payout ratio is 37.69%.
Analysts Set New Price Targets
Several research analysts recently issued reports on the company. Wells Fargo & Company raised their target price on Cardinal Health from $135.00 to $136.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 4th. Evercore ISI raised Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective on the stock in a research note on Tuesday, January 7th. JPMorgan Chase & Co. increased their target price on shares of Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a research report on Tuesday, February 4th. Mizuho boosted their price target on shares of Cardinal Health from $142.00 to $150.00 and gave the stock an “outperform” rating in a research report on Monday, March 31st. Finally, Citigroup increased their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research report on Friday, January 10th. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $140.14.
Check Out Our Latest Report on CAH
Cardinal Health Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories
- Five stocks we like better than Cardinal Health
- What is the Nasdaq? Complete Overview with History
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- Financial Services Stocks Investing
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- 5 Top Rated Dividend Stocks to Consider
- Spotify Stock Eyes Double-Digit UpsideāIs Now the Time to Buy?
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.